Lectin Therapy: A Way to Explore in Order to Inhibit the Binding of COVID-19 to these Host Cells

Fouad AKIF1

1

Publication Date: 2020/06/10

Abstract: When COVID-19 appeared in November 2019 in the city of Wuhan, in central China, no epidemiologist had predicted such a pandemic. Currently, no vaccine or drug is available, the treatment with azithromycin and hydroxychloroquine remains limited because it does not specifically target the viral pathogen

Keywords: COVID-19, Lectins, Drugs, Receptors, Glycans, Glycoproteins.

DOI: No DOI Available

PDF: https://ijirst.demo4.arinfotech.co/assets/upload/files/IJISRT20MAY426.pdf

REFERENCES

No References Available